Remedy Plan, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.remedyplan.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 1
1 (50.0%)Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
Not Applicable
Not yet recruiting
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Remedy Plan, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT07107126
A Study of RPT1G After Single and Multiple Doses in Healthy Adult Participants
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2025-09-02
- Lead Sponsor
- Remedy Plan, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT06667765
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, South Australia, Australia
News
No news found